MELBOURNE, Australia and INDIANAPOLIS, Nov. 11, 2026 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) will participate in the upcoming UBS Global Biopharma Conference in London (UK). Dr. Christian Behrenbruch, Managing Director and Group CEO, and Mr. Richard. ..
Telix to Participate in UBS Global Biopharma Conference
RELATED ARTICLES
